ACE and angioedema: Though the limitation of this study includes the few incidences of angioedema and selection bias for patients who have a lower risk of ACE inhibitor-induced angioedema (a common side effect of ACE inhibitor), this increased risk is something to be cautious of when prescribing both ACE inhibitors and DPP-IV inhibitors.